| Nome |
# |
|
Cisplatin and its dibromido analogue: a comparison of chemical and biological profiles, file e0d6c92b-8473-fcf8-e053-d805fe0aa794
|
259
|
|
Ruthenium arene complexes with triphenylphosphane ligands: Cytotoxicity towards pancreatic cancer cells, interaction with model proteins, and effect of ethacrynic acid substitution, file e0d6c929-c878-fcf8-e053-d805fe0aa794
|
215
|
|
Chlorido and bromido oxaliplatin analogues as potential agents for CRC treatment: Solution behavior, protein binding and cytotoxicity evaluation, file e0d6c92c-491d-fcf8-e053-d805fe0aa794
|
208
|
|
Synthesis, characterization and DNA interactions of [Pt3(TPymT)Cl3], the trinuclear platinum(II) complex of the TPymT ligand, file e0d6c92d-a4b5-fcf8-e053-d805fe0aa794
|
161
|
|
Photocytotoxic Pt(iv) complexes as prospective anticancer agents, file e0d6c930-daf9-fcf8-e053-d805fe0aa794
|
138
|
|
A focus on the biological targets for coinage metal-NHCs as potential anticancer complexes, file e0d6c930-4017-fcf8-e053-d805fe0aa794
|
108
|
|
Interaction of a Gold(I) Dicarbene Anticancer Drug with Human Telomeric DNA G-Quadruplex: Solution and Computationally Aided X-ray Diffraction Analysis, file e0d6c930-7175-fcf8-e053-d805fe0aa794
|
83
|
|
124I Radiolabeling of a AuIII-NHC Complex for In Vivo Biodistribution Studies, file e0d6c931-8767-fcf8-e053-d805fe0aa794
|
83
|
|
First Crystal Structure for a Gold Carbene-Protein Adduct, file e0d6c927-f06a-fcf8-e053-d805fe0aa794
|
78
|
|
cis-Pt I2(NH3)2: a reappraisal, file e0d6c930-ccbf-fcf8-e053-d805fe0aa794
|
62
|
|
PtI2(DACH), the Iodido Analogue of Oxaliplatin as a Candidate for Colorectal Cancer Treatment: Chemical and Biological Features, file e0d6c930-e03f-fcf8-e053-d805fe0aa794
|
61
|
|
Interaction of a Gold(I) Dicarbene Anticancer Drug with Human Telomeric DNA G-Quadruplex: Solution and Computationally Aided X-ray Diffraction Analysis, file e0d6c930-7100-fcf8-e053-d805fe0aa794
|
59
|
|
Mass spectrometry and metallomics: A general protocol to assess stability of metallodrug-protein adducts in bottom-up MS experiments, file e0d6c930-e08d-fcf8-e053-d805fe0aa794
|
59
|
|
Thermodynamic Evaluation of the Interactions between Anticancer Pt(II) Complexes and Model Proteins, file e0d6c930-dc77-fcf8-e053-d805fe0aa794
|
41
|
|
Auranofin, Et3PAuCl, and Et3PAuI Are Highly Cytotoxic on Colorectal Cancer Cells: A Chemical and Biological Study, file e0d6c930-e08c-fcf8-e053-d805fe0aa794
|
41
|
|
On the Different Mode of Action of Au(I)/Ag(I)-NHC Bis-Anthracenyl Complexes Towards Selected Target Biomolecules, file e0d6c92f-bb2f-fcf8-e053-d805fe0aa794
|
34
|
|
Synthesis, chemical characterization, and biological evaluation of a novel auranofin derivative as an anticancer agent, file 1f3a5910-b3e0-4311-9db0-cc93efadd50f
|
30
|
|
Protein metalation by two structurally related gold(I) carbene complexes: An ESI MS study, file e0d6c930-93f5-fcf8-e053-d805fe0aa794
|
28
|
|
Highlights of New Strategies to Increase the Efficacy of Transition Metal Complexes for Cancer Treatments, file 071daf00-562d-425a-9cc8-449e6470a0be
|
25
|
|
Anticancer gold N-Heterocyclic carbene complexes: a comparative in vitro and ex vivo study, file e0d6c931-2068-fcf8-e053-d805fe0aa794
|
25
|
|
Insights on the mechanism of thioredoxin reductase inhibition by Gold N-heterocyclic carbene compounds using the synthetic linear Selenocysteine containing C-terminal peptide hTrxR(488-499): An ESI-MS investigation, file e0d6c92e-f6dc-fcf8-e053-d805fe0aa794
|
24
|
|
Antiproliferative effects of two gold(I)-N-heterocyclic carbene complexes in A2780 human ovarian cancer cells: A comparative proteomic study, file e0d6c92b-996b-fcf8-e053-d805fe0aa794
|
19
|
|
Cytotoxic Ag(I) and Au(I) NHC-carbenes bind DNA and show TrxR inhibition, file e0d6c92e-bb15-fcf8-e053-d805fe0aa794
|
18
|
|
Reactions of cisplatin and cis-[PtI2(NH3)2] with molecular models of relevant protein sidechains: A comparative analysis, file e0d6c92e-f636-fcf8-e053-d805fe0aa794
|
15
|
|
Interaction of gold N-heterocyclic carbenes with nucleic acids, file e0d6c931-65d3-fcf8-e053-d805fe0aa794
|
14
|
|
Chemical Modification of Auranofin Yields a New Family of Anticancer Drug Candidates: The Gold(I) Phosphite Analogues, file 435a0e0e-8d7f-421c-b06f-81e77d5f9b9c
|
13
|
|
Chemistry and Biology of Two Novel Gold(I) Carbene Complexes as Prospective Anticancer Agents, file e0d6c926-4104-fcf8-e053-d805fe0aa794
|
13
|
|
Mechanistic Insights Into the Anticancer Properties of the Auranofin Analog Au(PEt3)I: A Theoretical and Experimental Study, file e0d6c92f-4a5e-fcf8-e053-d805fe0aa794
|
10
|
|
Synthesis, Characterization and Photoactivation Studies on the Novel Pt(IV)-Based [Pt(OCOCH3)3(phterpy)] Complex, file fde3eb63-f87b-4b23-93d3-7efd068218b7
|
9
|
|
Synthesis, Characterization and Photoactivation Studies on the Novel Pt(IV)-Based [Pt(OCOCH3)3(phterpy)] Complex, file 63bf7d86-845e-46b6-8f32-cbd744cc6e81
|
8
|
|
Peculiar features in the crystal structure of the adduct formed between cis-PtI2(NH3)2 and hen egg white lysozyme., file e0d6c928-d609-fcf8-e053-d805fe0aa794
|
8
|
|
Selected cytotoxic gold compounds cause significant inhibition of 20S proteasome catalytic activities, file e0d6c926-7d3b-fcf8-e053-d805fe0aa794
|
7
|
|
null, file 429573bc-331f-4211-8feb-cd822bf8bb1c
|
6
|
|
Potent in vitro antiproliferative properties for a triplatinum cluster toward triple negative breast cancer cells, file e0d6c92e-ddcf-fcf8-e053-d805fe0aa794
|
5
|
|
Organogold(III) compounds as experimental anticancer agents: chemical and biological profiles, file e0d6c927-ee12-fcf8-e053-d805fe0aa794
|
4
|
|
Potent in vitro antiproliferative properties for a triplatinum cluster toward triple negative breast cancer cells, file e0d6c927-ee20-fcf8-e053-d805fe0aa794
|
4
|
|
Cell and Cell-Free Mechanistic Studies on Two Gold(III) Complexes with Proven Antitumor Properties, file e0d6c928-f44c-fcf8-e053-d805fe0aa794
|
4
|
|
Interplay between Gold(I)-Ligand Bond Components and Hydrogen Bonding: A Combined Experimental/Computational Study, file e0d6c92d-4661-fcf8-e053-d805fe0aa794
|
4
|
|
Mass spectrometry and metallomics: A general protocol to assess stability of metallodrug-protein adducts in bottom-up MS experiments, file e0d6c928-f3a6-fcf8-e053-d805fe0aa794
|
3
|
|
Gold compounds as cysteine protease inhibitors: perspectives for pharmaceutical application as antiparasitic agents, file e0d6c928-f449-fcf8-e053-d805fe0aa794
|
3
|
|
PtI2(DACH), the Iodido Analogue of Oxaliplatin as a Candidate for Colorectal Cancer Treatment: Chemical and Biological Features, file e0d6c930-a6ae-fcf8-e053-d805fe0aa794
|
3
|
|
Auranofin, Et3PAuCl, and Et3PAuI Are Highly Cytotoxic on Colorectal Cancer Cells: A Chemical and Biological Study, file e0d6c930-aa7f-fcf8-e053-d805fe0aa794
|
3
|
|
Anticancer gold N-Heterocyclic carbene complexes: a comparative in vitro and ex vivo study, file e0d6c929-e67e-fcf8-e053-d805fe0aa794
|
2
|
|
Cytotoxic Ag(I) and Au(I) NHC-carbenes bind DNA and show TrxR inhibition, file e0d6c92e-ad64-fcf8-e053-d805fe0aa794
|
2
|
|
Reactions of cisplatin and cis-[PtI2(NH3)2] with molecular models of relevant protein sidechains: A comparative analysis, file e0d6c92e-f7e0-fcf8-e053-d805fe0aa794
|
2
|
|
New copper(II)/cyclic tetrapeptide system that easily oxidizes to copper(III) under atmospheric oxygen, file e0d6c92f-20d4-fcf8-e053-d805fe0aa794
|
2
|
|
Interaction of a Gold(I) Dicarbene Anticancer Drug with Human Telomeric DNA G-Quadruplex: Solution and Computationally Aided X-ray Diffraction Analysis, file e0d6c930-8ce9-fcf8-e053-d805fe0aa794
|
2
|
|
Synthesis, chemical characterization, and biological evaluation of a novel auranofin derivative as an anticancer agent, file 1e21d2cc-100e-4d42-94bc-978c8201e774
|
1
|
|
An overview of recent advancements in anticancer Pt(IV) prodrugs: New smart drug combinations, activation and delivery strategies, file df6fbc3a-8e5d-49e1-8d9c-8ab26f3dd023
|
1
|
|
Metal compounds as inhibitors of B-amyloid aggregation. Perspectives for an innovative metallotherapeutics on Alzheimer’s disease, file e0d6c928-e905-fcf8-e053-d805fe0aa794
|
1
|
|
Gold compounds as anticancer agents: chemistry, cellular pharmacology, and preclinical studies., file e0d6c928-eee4-fcf8-e053-d805fe0aa794
|
1
|
|
Thioredoxin reductase: A target for gold compounds acting as potential anticancer drugs, file e0d6c928-f452-fcf8-e053-d805fe0aa794
|
1
|
|
Synthesis, characterization and DNA interactions of [Pt3(TPymT)Cl3], the trinuclear platinum(II) complex of the TPymT ligand, file e0d6c92d-ac0e-fcf8-e053-d805fe0aa794
|
1
|
|
Insights on the mechanism of thioredoxin reductase inhibition by Gold N-heterocyclic carbene compounds using the synthetic linear Selenocysteine containing C-terminal peptide hTrxR(488-499): An ESI-MS investigation, file e0d6c92e-ddcb-fcf8-e053-d805fe0aa794
|
1
|
|
Reactions of medicinally relevant gold compounds with the C-terminal motif of thioredoxin reductase elucidated by MS analysis, file e0d6c92f-10c3-fcf8-e053-d805fe0aa794
|
1
|
|
Protein metalation by two structurally related gold(I) carbene complexes: An ESI MS study, file e0d6c930-8cb4-fcf8-e053-d805fe0aa794
|
1
|
|
cis-Pt I2(NH3)2: a reappraisal, file e0d6c930-bc43-fcf8-e053-d805fe0aa794
|
1
|
|
Thermodynamic Evaluation of the Interactions between Anticancer Pt(II) Complexes and Model Proteins, file e0d6c931-0180-fcf8-e053-d805fe0aa794
|
1
|
|
Photocytotoxic Pt(iv) complexes as prospective anticancer agents, file e0d6c931-29fc-fcf8-e053-d805fe0aa794
|
1
|
| Totale |
2.017 |